Skip to main content

Table 2 Blood pressure control by albuminuria and diabetes status among people on antihypertensive medication

From: Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary care

 

Diabetes, n = 276

No diabetes, n = 1150

Total n (%)

n (column%) unless otherwise stated

n (column%) unless otherwise stated

Albuminuria status

None (n = 195)

Micro albuminuria (n = 63)

Macro albuminuria (n = 18)

Subtotal diabetes

None (n = 981)

Micro albuminuria (n = 149)

Macro albuminuria (n = 20)

Subtotal no diabetes

n = 1426

Mean BP (SD)

Systolic

132 (17)

140 (20)

155 (22)

135 (19)

133 (18)

136 (19)

141 (18)

135 (18)

134 (18)

 

Diastolic

68 (10)

69 (10)

72 (11)

68 (10)

73 (11)

75 (11)

76 (9)

73 (11)

72 (11)

BP controlled (NICE target)*

Yes

84 (43.1)

19 (30.2)

3 (16.7)

106 (38.4)

631 (64.3)

86 (57.7)

6 (30.0)

723 (62.9)

829 (58.1)

 

No

111 (56.9)

44 (69.8)

15 (83.3)

170 (61.8)

350 (35.7)

63 (42.3)

14 (70.0)

425 (37.0)

597 (41.9)

BP controlled (KDOQI target)**

Yes

84 (43.1)

19 (30.2)

3 (16.7)

106 (38.4)

355 (36.2)

48 (32.2)

4 (20.0)

407 (35.3)

512 (35.9)

 

No

111 (56.9)

44 (69.8)

15 (83.3)

170 (61.8)

626 (63.8)

101 (67.8)

16 (80.0)

115 (68.9)

914 (64.1)

BP controlled (KDIGO target)***

Yes

141 (72.3)

21 (33.3)

3 (16.7)

165 (59.8)

639 (65.1)

52 (34.9)

4 (22.2)

695 (60.4)

859 (60.2)

 

No

54 (27.7)

42 (40.4)

15 (83.3)

111 (40.2)

342 (34.9)

97 (65.1)

14 (77.8)

453 (39.4)

576 (39.8)

Number of anti-hypertensive agents

1

79 (40.5)

25 (39.7)

3 (16.7)

107 (38.9)

433 (44.1)

65 (43.6)

8 (40.0)

506 (44.1)

615 (43.1)

 

2

54 (27.7)

19 (30.2)

5 (27.8)

78 (28.3)

345 (35.2)

61 (40.9)

4 (20.0)

410 (35.7)

488 (34.2)

 

3 or more

62 (31.8)

19 (30.2)

10 (55.6)

90 (32.6)

203 (20.7)

23 (15.4)

8 (40.0)

232 (20.2)

323 (22.7)

Taking RAASi

Yes

173 (88.7)

56 (88.9)

15 (83.3)

243 (88.4)

750 (76.5)

112 (75.2)

17 (85.0)

877 (76.4)

1123 (78.8)

 

No

22 (11.3)

7 (11.1)

3 (16.7)

32 (11.6)

231 (23.5)

37 (24.8)

3 (15.0)

271 (23.6)

303 (21.2)

  1. * <140/90 or <130/80 in people with diabetes and people with ACR > 70.
  2. ** <130/80 for all people with CKD.
  3. *** ≤ 140/90 or 130/80 in people with albuminuria.
  4. Microalbuminuria defined as ACR > =2.5 mg/mmol (men), > = 3.5 mg/mmol (women) in at least two of the three urine specimens.
  5. Macroalbuminuria defined as ACR ≥ 30 mg/mmol.
  6. Abbreviations:
  7. BP blood pressure.
  8. RAASi renin-angiotensin aldosterone system inhibitors.
  9. NICE National Institute for Health and Clinical Excellence.
  10. KDOQI National Kidney Foundation Kidney Disease Outcome Quality Initiative.
  11. ACR albumin/creatinine ratio.